At a glance
ClinicalIndex Comparison RecordN/ACompleted· 137 enrolled
Drug / intervention
Distraction +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Midazolam (Versed) and Distraction on Anxiety, Emergence Delirium, Sedation/Agitation, and Vomiting in Pre-operative Patients Ages 3 to 5.
In Brief
A clinical study evaluating Distraction and Usual care for Anxiety. Completed, enrolled 137 participants across 1 site.
Detailed Summary
Randomized control trial comparing usual care and distraction (tablet) on anxiety, emergence delirium, sedation/agitation, and vomiting in children 3-5 years old
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartApr 2017
Primary CompletionMar 2019
First PostedMay 2022
TodayJul 2026
First PostedMay 10, 2022
Enrollment StartApr 7, 2017
Primary CompletionMar 8, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.1 years ago
Interventions
Distractionbehavioral
Distraction (interactive tablet)
Usual careother
Anxiolytic ordered by anesthesiologist is usual care